Active	Status	Sponsor type	Region	Phase	Filter
5 Active 18 Inactive 23 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
recombinant human alkaline phosphatase intravenous (recAP) / AM Pharma
2019-004625-24: Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated Acute Kidney Injury	Not yet recruiting	3	1600	Europe, RoW	Recombinant Human Alkaline Phosphatase, recAP, Solution for infusion	AM-Pharma B.V., AM-Pharma B.V.	Sepsis-associated acute kidney injury, Sepsis-associated acute kidney injury, Body processes [G] - Immune system processes [G12]
NCT05890794: Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia	Completed	1/2	12	Europe	Ilofotase Alfa, 0.8 mg/kg, recAP, Ilofotase Alfa, 3.2 mg/kg	AM-Pharma	Hypophosphatasia	07/23	07/23
Travelan (IMM-124E) / Immuron
NCT05933525: Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model	Active, not recruiting	2	60	US	Travelan, IMM-124E, Placebo, ProMilk 85 milk powder	Immuron Ltd., United States Department of Defense, Naval Medical Research Center	Diarrhea, Travelers Diarrhea, Infectious Diarrhea	04/24	07/24
NCT04643561: Using Travelan to Boost Immune Response in Vitro to COVID-19	Active, not recruiting	1/2	5	RoW	Travelan OTC	Hadassah Medical Organization	Covid19	12/20	12/20
NCT04605783: Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel	Recruiting	N/A	866	Europe, US	Travelan®, Placebo	Henry M. Jackson Foundation for the Advancement of Military Medicine, Uniformed Services University of the Health Sciences	Diarrhea	10/24	01/25
murepavadin (POL7080) / Spexis
No trials found